-+ 0.00%
-+ 0.00%
-+ 0.00%

BRIGHT MINDS BIOSCIENCES - PARTIAL CLINICAL HOLD APPLIES ONLY TO PLANNED PHASE 2 TRIAL OF BMB-101 IN U.S.

Reuters·11/02/2026 12:33:17